145 related articles for article (PubMed ID: 12027100)
1. Experimental photodynamic effects of hypocrellin A on the choriocapillaris.
Khoobehi B; Grinstead R; Passos E
Ophthalmic Surg Lasers; 2002; 33(3):207-13. PubMed ID: 12027100
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2).
Peyman GA; Moshfeghi DM; Moshfeghi A; Khoobehi B; Doiron DR; Primbs GB; Crean DH
Ophthalmic Surg Lasers; 1997 May; 28(5):409-17. PubMed ID: 9150524
[TBL] [Abstract][Full Text] [Related]
3. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
[TBL] [Abstract][Full Text] [Related]
4. Retinal injury thresholds for 532, 578, and 630 nm lasers in connection to photodynamic therapy for choroidal neovascularization.
Chen H; Yang Z; Zou X; Wang J; Zhu J; Gu Y
Lasers Surg Med; 2014 Jan; 46(1):54-60. PubMed ID: 24307505
[TBL] [Abstract][Full Text] [Related]
5. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
[TBL] [Abstract][Full Text] [Related]
6. Threshold power levels for NPe6 photodynamic therapy.
Kazi AA; Peyman GA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi D; Moshfeghi AA
Ophthalmic Surg Lasers; 2000; 31(2):136-42. PubMed ID: 10743925
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.
Framme C; Sachs HG; Flucke B; Theisen-Kunde D; Birngruber R
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5437-46. PubMed ID: 17122134
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative.
Young LH; Howard MA; Hu LK; Kim RY; Gragoudas ES
Arch Ophthalmol; 1996 Feb; 114(2):186-92. PubMed ID: 8573023
[TBL] [Abstract][Full Text] [Related]
9. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies.
Moshfeghi DM; Peyman GA; Moshfeghi AA; Khoobehi B; Primbs GB; Crean DH
Ophthalmic Surg Lasers; 1998 Aug; 29(8):663-8. PubMed ID: 9715492
[TBL] [Abstract][Full Text] [Related]
10. Problems with and pitfalls of photodynamic therapy.
Peyman GA; Kazi AA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi DM
Ophthalmology; 2000 Jan; 107(1):29-35. PubMed ID: 10647715
[TBL] [Abstract][Full Text] [Related]
11. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
13. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization.
Husain D; Miller JW; Michaud N; Connolly E; Flotte TJ; Gragoudas ES
Arch Ophthalmol; 1996 Aug; 114(8):978-85. PubMed ID: 8694734
[TBL] [Abstract][Full Text] [Related]
14. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
Nakashizuka T; Mori K; Hayashi N; Anzail K; Kanail K; Yoneya S; Moshfeghi DM; Peyman GA
Retina; 2001; 21(5):493-8. PubMed ID: 11642379
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of photodynamic occlusion using liposomal Zn(II)-phtalocyanine.
Schmidt-Erfurth U; Michels S; Indorf L; Eggers R; Birngruber R
Curr Eye Res; 2005 Jul; 30(7):601-12. PubMed ID: 16020295
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy.
Wang ZJ; He YY; Huang CG; Huang JS; Huang YC; An JY; Gu Y; Jiang LJ
Photochem Photobiol; 1999 Nov; 70(5):773-80. PubMed ID: 10568169
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of photopoint photosensitizer mv6401, indium chloride methyl pyropheophorbide, as a photodynamic therapy agent in primate choriocapillaris and laser-induced choroidal neovascularization.
Ciulla TA; Criswell MH; Danis RP; Snyder WJ; Small W
Retina; 2004 Aug; 24(4):521-9. PubMed ID: 15300072
[TBL] [Abstract][Full Text] [Related]
18. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
Peyman GA; Kazi AA; Moshfeghi D; Unal M; Khoobehi B; Yoneya S; Mori K; Rivera I
Ophthalmic Surg Lasers; 2000; 31(4):323-7. PubMed ID: 10928670
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antitumor activity of a novel hypocrellin B derivative for photodynamic therapy.
Zhao H; Yin R; Chen D; Ren J; Wang Y; Zhanga J; Deng H; Wang Y; Qiu H; Huang N; Zou Q; Zhao J; Gu Y
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):204-12. PubMed ID: 24534694
[TBL] [Abstract][Full Text] [Related]
20. A new Chlorin formulation promotes efficient photodynamic action in choriocapillaris of rabbit's eyes.
Salomao GHA; Fernandes AU; Baptista MS; Tardivo JP; Gianssante S; Veridiano JM; Toledo OMS; Petri G; Christofolini DM; Correa JA
Bioorg Med Chem Lett; 2018 Jun; 28(10):1870-1873. PubMed ID: 29661534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
